Legalised cannabis is set to arrive in Canada later this year, following the country’s historic vote last month to become the first G7 nation to allow the drug’s recreational use. As a result, the Canadian marijuana industry is expected to grow into a multibillion-dollar sector, reaching C$6.5 billion by 2020, per the Canadian Imperial Bank of Commerce.
Europe’s population is more than twice the size of the US and Canada’s combined, suggesting the potential of a considerably larger cannabis market that could be cultivated. While estimates vary, market intelligence business Prohibition Partners suggests that with around 12% of the continent’s population being “irregular” or “intensive” users, a fully legal and regulated cannabis market would be worth north of €56 billion annually. Within the larger industry, the medical cannabis market alone would have the potential to reach nearly an estimated €36 billion, according to the same research.
Sativa Investments plc (NEX:SATI) seeks to invest in global companies which are well-placed to take advantage of the dynamic regulatory environment surrounding medical Cannabis. Our investment strategy focuses on production, pharmacology, testing and compliance, R&D commercialisation, and sales and marketing.